Literature DB >> 9135890

A role for molecular radiobiology in radiotherapy?

A T Gordon1, T J McMillan.   

Abstract

As we learn more about the cellular response to radiation and its genetic control, new avenues are opened up that have the potential to have a significant impact on radiotherapy practice. The recognition of the importance of the control of DNA damage induction and repair, cell cycle arrest and apoptosis gives us the primary areas to investigate, and the improvements in molecular technology make the application of our new knowledge more feasible. It can only be hoped that specific means can be found to assist in the prediction of normal tissue and tumour radiosensitivity and to manipulate sensitivity when that is desirable.

Entities:  

Mesh:

Year:  1997        PMID: 9135890     DOI: 10.1016/s0936-6555(05)80443-1

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  2 in total

1.  HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells.

Authors:  Xufeng Chen; Patty Wong; Eric Radany; Jeffrey Y C Wong
Journal:  Cancer Biother Radiopharm       Date:  2009-12       Impact factor: 3.099

2.  Radiosensitivity of human ovarian carcinoma and melanoma cells to γ-rays and protons.

Authors:  Otilija Keta; Danijela Todorović; Nataša Popović; Lela Korićanac; Giacomo Cuttone; Ivan Petrović; Aleksandra Ristić-Fira
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.